- Home
- JAZZ vs MTCH Comparison
JAZZ vs MTCH Comparison
Compare JAZZ & MTCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- MTCH
- Stock Information
- Founded
- JAZZ 2003
- MTCH 1986
- Country
- JAZZ Ireland
- MTCH United States
- Employees
- JAZZ N/A
- MTCH N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- MTCH Computer Software: Programming Data Processing
- Sector
- JAZZ Health Care
- MTCH Technology
- Exchange
- JAZZ Nasdaq
- MTCH Nasdaq
- Market Cap
- JAZZ 7.1B
- MTCH 8.2B
- IPO Year
- JAZZ 2007
- MTCH 2015
- Fundamental
- Price
- JAZZ $124.15
- MTCH $37.42
- Analyst Decision
- JAZZ Strong Buy
- MTCH Hold
- Analyst Count
- JAZZ 12
- MTCH 16
- Target Price
- JAZZ $182.75
- MTCH $35.44
- AVG Volume (30 Days)
- JAZZ 879.8K
- MTCH 4.9M
- Earning Date
- JAZZ 08-05-2025
- MTCH 08-05-2025
- Dividend Yield
- JAZZ N/A
- MTCH 2.03%
- EPS Growth
- JAZZ N/A
- MTCH N/A
- EPS
- JAZZ N/A
- MTCH 2.03
- Revenue
- JAZZ $4,086,695,000.00
- MTCH $3,450,576,000.00
- Revenue This Year
- JAZZ $5.65
- MTCH $2.43
- Revenue Next Year
- JAZZ $5.79
- MTCH $4.49
- P/E Ratio
- JAZZ N/A
- MTCH $18.41
- Revenue Growth
- JAZZ 4.52
- MTCH N/A
- 52 Week Low
- JAZZ $95.49
- MTCH $26.39
- 52 Week High
- JAZZ $148.06
- MTCH $39.20
- Technical
- Relative Strength Index (RSI)
- JAZZ 66.76
- MTCH 61.18
- Support Level
- JAZZ $122.50
- MTCH $37.00
- Resistance Level
- JAZZ $126.14
- MTCH $37.73
- Average True Range (ATR)
- JAZZ 2.50
- MTCH 0.93
- MACD
- JAZZ 0.80
- MTCH -0.15
- Stochastic Oscillator
- JAZZ 87.44
- MTCH 57.31
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.